{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:12:25Z","timestamp":1790079145771,"version":"4.0.1"},"reference-count":30,"publisher":"Informa UK Limited","issue":"13","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["13Y-NS-O021"],"award-info":[{"award-number":["13Y-NS-O021"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2026,5,28]]},"DOI":"10.1080\/14796694.2026.2672132","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T08:18:08Z","timestamp":1779437888000},"page":"1533-1539","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7296-8227","authenticated-orcid":false,"given":"Helena","family":"Harder","sequence":"first","affiliation":[{"name":"University of Sussex","place":["Brighton, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8939-0081","authenticated-orcid":false,"given":"Val","family":"Jenkins","sequence":"additional","affiliation":[{"name":"University of Sussex","place":["Brighton, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0577-4518","authenticated-orcid":false,"given":"Lesley","family":"Fallowfield","sequence":"additional","affiliation":[{"name":"University of Sussex","place":["Brighton, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"e_1_3_9_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_9_4_1","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v5.i3.412"},{"key":"e_1_3_9_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1701830"},{"key":"e_1_3_9_6_1","unstructured":"National Institute for Health and Care Excellence. Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive HER2-negative node-positive early breast cancer at high risk of recurrence. 2022. Technology appraisal guidance (TA810). https:\/\/www.nice.org.uk\/guidance\/ta810"},{"key":"e_1_3_9_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.02742"},{"key":"e_1_3_9_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.23.01994"},{"key":"e_1_3_9_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.02514"},{"key":"e_1_3_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102624"},{"key":"e_1_3_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.03.006"},{"key":"e_1_3_9_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12609-025-00576-3"},{"key":"e_1_3_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.113555"},{"key":"e_1_3_9_14_1","unstructured":"National Cancer Institute (NCI). Common terminology criteria for adverse events (CTCAE) version 6.0 (MedDRA 28.0). U.S. Department of Health and Human Services; 2025. Available from: https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v6.pdf"},{"key":"e_1_3_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102941"},{"key":"e_1_3_9_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32898"},{"key":"e_1_3_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.05.041"},{"key":"e_1_3_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-022-06518-2"},{"key":"e_1_3_9_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4055"},{"key":"e_1_3_9_20_1","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.S319239"},{"key":"e_1_3_9_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09440-7"},{"key":"e_1_3_9_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-025-09444-3"},{"key":"e_1_3_9_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-14"},{"key":"e_1_3_9_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-117"},{"key":"e_1_3_9_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"},{"key":"e_1_3_9_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-076798"},{"key":"e_1_3_9_27_1","doi-asserted-by":"publisher","DOI":"10.2147\/ppa.S432821"},{"key":"e_1_3_9_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2021.1852934"},{"key":"e_1_3_9_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-08170-y"},{"key":"e_1_3_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2024.12.001"},{"key":"e_1_3_9_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/08870446.2019.1579910"},{"key":"e_1_3_9_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07414-w"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2672132","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14796694.2026.2672132","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2672132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:39:33Z","timestamp":1790077173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2026.2672132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":30,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,5,28]]}},"alternative-id":["10.1080\/14796694.2026.2672132"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2026.2672132","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}